Dendreon looks to cut manufacturing costs; Express Scripts pays $2.75 million fine;

> Dendreon ($DNDN), which makes prostate cancer drug Provenge, is looking at how to make its manufacturing more efficient since the cost of producing the drug is a drag on earnings. Story

> Contract manufacturer Akela Pharma reported earning $800,000 in the last quarter compared with $3.5 million a year earlier. Item

> Biologics manufacturer Lonza has a new contract to manufacture products for Avalanche Biotechnologies, whose lead wet age-related macular degeneration gene therapy candidate AVA-101 started clinical trials last year. Item

> Fette Compacting has a new tableting center in Campinas, near São Paulo, Brazil. Item

> The pharmacy benefits manager Express Scripts will pay a $2.75 million fine to settle charges that it didn't have adequate provisions in place at distribution centers to prevent employee theft of controlled substances. Story

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.